Clinical Trials: Oral Complications of Cancer Therapy (R21)
National Institutes of Health · Opportunity PAR-06-213
Deadline
Rolling / TBD
Multiple Receipt Dates - See Link to Full Announcement for details.
Award range
— – $200k
Total program funding
—
PostedMarch 7, 2006
Who can apply
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities
- Native American tribal organizations (other)
- Nonprofits with 501(c)(3), other than higher education
- Nonprofits without 501(c)(3)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Others
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government are eligible to apply.
About this opportunity
The NIDCR and NCI invites applications for clinical research directed at reducing the incidence and severity of oral complications from cancer therapies. The development of a Clinical Pilot Data Grants under this FOA would be to collect preliminary data to establish an adequate foundation for a future Phase III clinical trial.
Similar grants still open
| Opportunity | Agency | Deadline | Award ceiling | Eligible |
|---|---|---|---|---|
| Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) | National Institutes of Health | August 18, 2026 23d left | — | Nonprofits |
| Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) | National Institutes of Health | September 7, 2026 43d left | $499k | Nonprofits |
| Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) | National Institutes of Health | September 7, 2026 43d left | — | Nonprofits |
| Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed) | National Institutes of Health | September 7, 2026 43d left | — | Nonprofits |